Trade CRDL stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Cardiol Therapeutics Inc. Class A Common Shares (CRDL) is trading at US$1.88, up 0.81% today as of Sep 18, 16:00 EDT. The company has a market capitalisation of US$217.29M. Over the past 52 weeks, CRDL has traded between US$0.88 and US$2.34. On Syfe you can trade CRDL with $0 commission and add it to your watchlist.
| Previous close | US$1.86 |
|---|---|
| Market cap | US$217.29M |
| 52-week range | US$0.88 – US$2.34 |
| Volume | 967.61K |
| Exchange | US |
Add to Watchlist
Set Price Alert
Cardiol Therapeutics Inc. Class A Common Shares
Cardiol Therapeutics, Inc. is a clinical-stage life sciences company focused on the research and clinical of anti-inflammatory and anti-fibrotic therapies for the treatment of heart disease. Its lead product candidate, CardiolRx, is a pharmaceutically manufactured oral cannabidiol formulation that is being clinically developed for use in heart diseases. The firm is conducting clinical studies to evaluate the efficacy and safety of CardiolRx in diseases affecting the heart: a Phase II multi-national, randomized, double-blind, placebo-controlled trial (the ARCHER trial) in acute myocarditis; and a Phase II multi-center open-label pilot study in recurrent pericarditis. It is also involved in developing a novel subcutaneously administered drug formulation of cannabidiol intended for use in heart failure. The company was founded by David Elsley, Eldon Smith, and Anthony Bolton on January 19, 2017 and is headquartered in Oakville, Canada.
Year: 2019
Stay on top of CRDL
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
Popular Stocks in Singapore
